William Blair Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32M | Sell |
490,536
-37,740
| -7% | -$2.46M | 0.08% | 193 |
|
|
2025
Q1 | $35.4M | Buy |
528,276
+43,008
| +9% | +$2.88M | 0.1% | 184 |
|
|
2024
Q4 | $26.8M | Buy |
485,268
+10,440
| +2% | +$577K | 0.07% | 273 |
|
|
2024
Q3 | $28.3M | Sell |
474,828
-14,558
| -3% | -$869K | 0.07% | 248 |
|
|
2024
Q2 | $31.2M | Sell |
489,386
-879
| -0.2% | -$56K | 0.08% | 214 |
|
|
2024
Q1 | $33.9M | Sell |
490,265
-292
| -0.1% | -$20.2K | 0.09% | 223 |
|
|
2023
Q4 | $27M | Sell |
490,557
-9,502
| -2% | -$524K | 0.08% | 248 |
|
|
2023
Q3 | $29M | Sell |
500,059
-39,069
| -7% | -$2.27M | 0.1% | 224 |
|
|
2023
Q2 | $29M | Buy |
539,128
+9,998
| +2% | +$538K | 0.09% | 236 |
|
|
2023
Q1 | $21M | Buy |
529,130
+1,665
| +0.3% | +$66.1K | 0.07% | 276 |
|
|
2022
Q4 | $21.2M | Sell |
527,465
-19,924
| -4% | -$802K | 0.08% | 255 |
|
|
2022
Q3 | $17.6M | Sell |
547,389
-9,665
| -2% | -$311K | 0.07% | 266 |
|
|
2022
Q2 | $16.5M | Sell |
557,054
-14,126
| -2% | -$419K | 0.06% | 276 |
|
|
2022
Q1 | $16.1M | Buy |
571,180
+119,736
| +27% | +$3.37M | 0.05% | 304 |
|
|
2021
Q4 | $20.8M | Buy |
451,444
+77,338
| +21% | +$3.56M | 0.06% | 292 |
|
|
2021
Q3 | $12.3M | Buy |
374,106
+373,351
| +49,450% | +$12.3M | 0.03% | 349 |
|
|
2021
Q2 | $26K | Buy |
+755
| New | +$26K | ﹤0.01% | 461 |
|